Advisor Group Holdings, Inc. Orchard Therapeutics PLC Transaction History

Advisor Group Holdings, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.36 - $0.49 $1,852 - $2,521	5,145 Added 259.98%	7,124 $2,000
Q3 2021 Nov 05, 2021	SELL	$2.24 - $4.29 $150 - $287	-67 Reduced 3.27%	1,979 $4,000
Q2 2021 Aug 02, 2021	SELL	$4.39 - $7.23 $4,881 - $8,039	-1,112 Reduced 35.21%	2,046 $10,000
Q1 2021 May 13, 2021	BUY	$4.39 - $9.08 $12,195 - $25,224	2,778 Added 731.05%	3,158 $23,000
Q4 2020 Feb 10, 2021	SELL	$3.86 - $5.07 $312 - $410	-81 Reduced 17.57%	380 $2,000
Q3 2020 Nov 12, 2020	BUY	$4.11 - $6.45 $1,561 - $2,451	380 Added 469.14%	461 $2,000
Q1 2020 May 18, 2020	BUY	$5.65 - $15.71 $457 - $1,272	81 New	81 $1,000

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.